Security · CUSIP 517954103
LATIGO BIOTHERAPEUTICS INC
COM · institutional ownership from 13F filings
Q3 2026 is still being filed (deadline 45 days after quarter end), so holder counts are incomplete.
13F holders
6
Shares held
1.8M
Value held
$30.8M
New / sold out
6 / 0
Added / reduced
0 / 0
net +1.8M shares
13F holders by quarter
Net shares bought by existing holders
Top holders · Q3 2026
| Manager | Shares | Value | % of portfolio |
|---|---|---|---|
| Aberdeen Group plc | 935,718 | $15.6M | 0.02% |
| Sanofi | 672,778 | $11.2M | 1.78% |
| GEODE CAPITAL MANAGEMENT, LLC | 220,175 | $3.7M | 0.00% |
| Cambridge Investment Research Advisors, Inc. | 13,888 | $232.0K | 0.00% |
| CITIGROUP INC | 1,168 | $19.5K | 0.00% |
| Jacobi Capital Management LLC | 30 | $501 | 0.00% |
Biggest buyers
| Manager | Change | Shares change | Change % |
|---|---|---|---|
| Aberdeen Group plc | New | +935,718 | – |
| Sanofi | New | +672,778 | – |
| GEODE CAPITAL MANAGEMENT, LLC | New | +220,175 | – |
| Cambridge Investment Research Advisors, Inc. | New | +13,888 | – |
| CITIGROUP INC | New | +1,168 | – |
| Jacobi Capital Management LLC | New | +30 | – |
Biggest sellers
Nothing to show.